comparemela.com
Home
Live Updates
Molecure to regain worldwide rights to dual chitinase inhibitor OATD-01 : comparemela.com
Molecure to regain worldwide rights to dual chitinase inhibitor OATD-01
/PRNewswire/ -- Molecure S.A. ("Molecure": WSE: MOC) a clinical stage biotechnology company that uses its world leading medicinal capabilities to discover and...
Related Keywords
United States ,
Poland ,
Warsaw ,
L67 ,
Eleanor Perkin ,
Frazer Hall ,
Samson Fung ,
Marcin Szumowski ,
Andre Hoekema ,
Magdalena Licka ,
Sandi Greenwood ,
Youtube ,
Linkedin ,
Twitter ,
Warsaw Stock Exchange ,
International Institute Of Molecular ,
Chief Business Officer ,
David Dible ,
International Institute ,
Cell Biology ,
Molecure ,
comparemela.com © 2020. All Rights Reserved.